These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9297348)

  • 1. [Changes in certain indicators of hemostasis in rabbits upon administration of Ebola virus preparations].
    Chepurnov AA; Dadaeva AA; Sizikova LP; Pisanko VA
    Vopr Virusol; 1997; 42(3):140-3. PubMed ID: 9297348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Change in biochemical and hemostatic indicators in guinea pigs upon administering Ebola virus preparations].
    Chepurnov AA; Dadaeva AA; Zhukov VA; Sizikov LP; Merzlikin NV
    Vopr Virusol; 1997; 42(4):171-5. PubMed ID: 9304298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamics of immunologic indicators in guinea pigs upon administering various preparations of the Ebola virus].
    Dadaeva AA; Sizikova LP; Zhukov VA; Chepurnov AA
    Vopr Virusol; 1998; 43(4):163-9. PubMed ID: 9791881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of repeated administration of Ebola virus preparations on dynamics of immunologic parameters].
    Chepurnov AA; Dadaeva AA; Sizikova LP
    Biull Eksp Biol Med; 1999 Jan; 127(1):81-5. PubMed ID: 10190013
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the phagocytic ability of blood polymorphonuclear leukocytes from rabbits and guinea pigs upon administering Ebola virus].
    Dadaveva AA; Sizikova LP; Bakulina LF; Chepurnov AA
    Vopr Virusol; 1997; 42(2):56-9. PubMed ID: 9182399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation of rabbit antiserum to Ebola virus].
    Chepurnov AA; Merzlikin NV; Chepurnova TS; Vorob'eva MS
    Vopr Virusol; 1994; 39(6):286-8. PubMed ID: 7716928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of an infections dose of the Ebola virus on survivability and immunologic indicators in guinea pigs].
    Dadaeva AA; Chepurnov AA; Sizikova LP; Chepurnova TS
    Vopr Virusol; 1999; 44(5):217-20. PubMed ID: 10544449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunobiological properties of vp24 protein of Ebola virus expressed by recombinant vaccinia virus].
    Chepurnov AA; Ternovoĭ VA; Dadaeva AA; Dmitriev IP; Sizikova LP; Volchkov VE; Kudoiarova NM; Rudzevich TN; Netesov SV
    Vopr Virusol; 1997; 42(3):115-20. PubMed ID: 9297340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge.
    Bukreyev A; Yang L; Zaki SR; Shieh WJ; Rollin PE; Murphy BR; Collins PL; Sanchez A
    J Virol; 2006 Mar; 80(5):2267-79. PubMed ID: 16474134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antigenic structure of Ebola virus VP35 protein].
    Kazachinskaia EI; Ternovoĭ VA; Rudzevich TN; Netesov SV; Chepurnov AA; Razumov IA
    Vopr Virusol; 2001; 46(5):25-31. PubMed ID: 11715705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Attempts to develop a vaccine against Ebola fever].
    Chupurnov AA; Chernukhin IV; Ternovoĭ VA; Kudoiarova NM; Makhova NM; Azaev MSh; Smolina MP
    Vopr Virusol; 1995; 40(6):257-60. PubMed ID: 8686261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebola virus: the search for vaccines and treatments.
    Wilson JA; Bosio CM; Hart MK
    Cell Mol Life Sci; 2001 Nov; 58(12-13):1826-41. PubMed ID: 11766882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.
    Gupta M; Mahanty S; Bray M; Ahmed R; Rollin PE
    J Virol; 2001 May; 75(10):4649-54. PubMed ID: 11312335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation in nonhuman primates of vaccines against Ebola virus.
    Geisbert TW; Pushko P; Anderson K; Smith J; Davis KJ; Jahrling PB
    Emerg Infect Dis; 2002 May; 8(5):503-7. PubMed ID: 11996686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses.
    Marzi A; Feldmann F; Geisbert TW; Feldmann H; Safronetz D
    Emerg Infect Dis; 2015 Feb; 21(2):305-7. PubMed ID: 25625358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of Ebola virus reproduction in adult ICR white mice].
    Chepurnov AA; Sizikova LP; Shalemba-Chepurnova AA; Shestopalova LV
    Vopr Virusol; 2010; 55(4):33-8. PubMed ID: 20886711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic response to Mannheimia haemolytica in calves concurrently inoculated with inactivated or modified-live preparations of M. haemolytica and viral combination vaccines containing modified-live bovine herpesvirus type 1.
    Cortese VS; Seeger JT; Stokka GS; Hunsaker BD; Lardy GP; Weigel DJ; Brumbaugh GW
    Am J Vet Res; 2011 Nov; 72(11):1541-9. PubMed ID: 22023134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein.
    Wilson JA; Hart MK
    J Virol; 2001 Mar; 75(6):2660-4. PubMed ID: 11222689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola virus: from discovery to vaccine.
    Feldmann H; Jones S; Klenk HD; Schnittler HJ
    Nat Rev Immunol; 2003 Aug; 3(8):677-85. PubMed ID: 12974482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Potential vaccine candidates against Ebola and the first vaccine against chikungunya virus infection].
    Nau JY
    Rev Med Suisse; 2014 Aug; 10(439):1570-1. PubMed ID: 25272676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.